Ola Myklebost combines Gene and Phenotype in his research. He undertakes multidisciplinary investigations into Genetics and Molecular biology in his work. Ola Myklebost applies his multidisciplinary studies on Molecular biology and Genetics in his research. Ola Myklebost undertakes multidisciplinary studies into Chromosome and Gene duplication in his work. He integrates Gene duplication with Chromosome in his study. In his work, Ola Myklebost performs multidisciplinary research in Karyotype and Trisomy. Trisomy and Aneuploidy are two areas of study in which Ola Myklebost engages in interdisciplinary research. Ola Myklebost integrates many fields, such as Aneuploidy and Karyotype, in his works. With his scientific publications, his incorporates both Comparative genomic hybridization and Cytogenetics.
Gene connects with themes related to Somatic evolution in cancer in his study. Ola Myklebost incorporates Genetics and Cell biology in his studies. As part of his studies on Cell biology, Ola Myklebost frequently links adjacent subjects like Signal transduction. He conducts interdisciplinary study in the fields of Signal transduction and Downregulation and upregulation through his research. Ola Myklebost performs multidisciplinary study on Downregulation and upregulation and Apoptosis in his works. By researching both Apoptosis and Cell cycle checkpoint, he produces research that crosses academic boundaries. In his research, Ola Myklebost undertakes multidisciplinary study on Cancer research and Tumor suppressor gene. He merges Molecular biology with Complementary DNA in his research. Ola Myklebost performs multidisciplinary study on Complementary DNA and Molecular biology in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy.
Nature Biotechnology (2006)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.
J. Herz;U. Hamann;S. Rogne;Ola Myklebost.
The EMBO Journal (1988)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
Christian Tovar;James Rosinski;Zoran Filipovic;Brian Higgins.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl.
Nature Genetics (2013)
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
Jose M. C. Tubio;Yilong Li;Young Seok Ju;Inigo Martincorena.
Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
Emilie P. Buddingh;Marieke L. Kuijjer;Ronald A J Duim;Horst Bürger.
Clinical Cancer Research (2011)
Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
Heidi M. Namløs;Leonardo A. Meza-Zepeda;Leonardo A. Meza-Zepeda;Tale Barøy;Ingrid H G Østensen.
PLOS ONE (2012)
Structure of the Supernumerary Ring and Giant Rod Chromosomes in Adipose Tissue Tumors
Florence Pedeutour;Anne Forus;Jean Michel Coindre;Jeanne Marie Berner.
Genes, Chromosomes and Cancer (1999)
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
Vivi Ann Flørenes;Steinar Aamdal;Ola Myklebost;Gunhild M. Maelandsmo.
Cancer Research (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: